Jazz Pharmaceuticals (JAZZ) PT Raised to $175 at Deutsche Bank
Tweet
Share
E-mail
Get Alerts JAZZ Hot Sheet
Price: $243.47 +2.51%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Deutsche Bank raised its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $175.00 (from $174.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pembina Pipeline Corp. (PPL:CN) (PBA) PT Raised to Cdn$73 at CIBC
- Wipro Ltd. (WPRO:IN) (WIT) PT Lowered to INR170 at BNP Paribas Exane
- Tech Mahindra Ltd. (TECHM:IN) PT Lowered to INR1,775 at BNP Paribas Exane
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
